Does Dr. MOUHANNA ABU GHANIMEH have financial conflicts of interest?

Dr. MOUHANNA ABU GHANIMEH (M.D.) has received a total of $8,117 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $8,117 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MOUHANNA ABU GHANIMEH?

According to CMS Open Payments data, Dr. MOUHANNA ABU GHANIMEH received funding from BOSTON SCIENTIFIC CORPORATION ($4,708), OLYMPUS CORPORATION OF THE AMERICAS ($1,863), and OVESCO ENDOSCOPY USA ($1,247).

Does Dr. MOUHANNA ABU GHANIMEH receive research grants or speaking fees?

Dr. MOUHANNA ABU GHANIMEH has received $8,117 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MOUHANNA ABU GHANIMEH

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Gastroenterology

Practice Location: SIOUX FALLS, SD 57105

NPI Number: 1962812982

LIFETIME INDUSTRY VALUE

$8,117

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ABU GHANIMEH is a verified Internal Medicine, Gastroenterology practitioner based in SIOUX FALLS, SD.

Between 2021 and 2025, Dr. ABU GHANIMEH had an overall industry promotional and research financial footprint of $8,117 as recorded in the federal CMS Open Payments database.

$8,117 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABU GHANIMEH's primary funding source is BOSTON SCIENTIFIC CORPORATION, which accounts for $4,708 (representing 58% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOSTON SCIENTIFIC CORPORATION

Rank 1

$4,708

58%

OLYMPUS CORPORATION OF THE AMERICAS

Rank 2

$1,863

23%

OVESCO ENDOSCOPY USA

Rank 3

$1,247

15.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.